» Articles » PMID: 33902476

Diagnostic Value of Neutrophil CD64, Procalcitonin, and Interleukin-6 in Sepsis: a Meta-analysis

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2021 Apr 27
PMID 33902476
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The aim of the study was to conduct a meta-analysis to evaluate the accuracy of neutrophil CD64, procalcitonin (PCT), and interleukin-6 (IL-6) as markers for the diagnosis of sepsis in adult patients.

Methods: Various databases were searched to collect published studies on the diagnosis of sepsis in adult patients using neutrophil CD64, PCT, and IL-6 levels. Utilizing the Stata SE 15.0 software, forest plots and the area under the summary receiver operating characteristic curves were drawn. The pooled sensitivity, specificity, positive likelihood ratio, negative likelihood ratio, diagnostic odds ratio, and area under the curve (AUC) were calculated.

Results: Fifty-four articles were included in the study. The pooled sensitivity, specificity, and AUC of neutrophil CD64 for the diagnosis of sepsis were 0.88 (95% confidence interval [CI], 0.81-0.92), 0.88 (95% CI, 0.83-0.91), and 0.94 (95% CI, 0.91-0.96), respectively. The pooled sensitivity, specificity, and AUC of PCT for the diagnosis of sepsis were 0.82 (95% CI, 0.78-0.85), 0.78 (95% CI, 0.74-0.82), and 0.87 (95% CI, 0.83-0.89), respectively. Subgroup analysis showed that the AUC for PCT diagnosis of intensive care unit (ICU) sepsis was 0.86 (95% CI, 0.83-0.89) and the AUC for PCT diagnosis of non-ICU sepsis was 0.82 (95% CI, 0.78-0.85). The pooled sensitivity, specificity, and AUC of IL-6 for the diagnosis of sepsis were 0.72 (95% CI, 0.65-0.78), 0.70 (95% CI, 0.62-0.76), and 0.77 (95% CI, 0.73-0.80), respectively.

Conclusions: Of the three biomarkers studied, neutrophil CD64 showed the highest diagnostic value for sepsis, followed by PCT, and IL-6. On the other hand, PCT showed a better diagnostic potential for the diagnosis of sepsis in patients with severe conditions compared with that in patients with non-severe conditions.

Citing Articles

Malocclusion Worsens Survival Following Sepsis Due to the Disruption of Innate and Acquired Immunity.

Fujinami Y, Saito M, Ono Y, Akashi M, Inoue S, Kotani J Int J Mol Sci. 2025; 26(5).

PMID: 40076520 PMC: 11899844. DOI: 10.3390/ijms26051894.


Can nCD64 and mCD169 biomarkers improve the diagnosis of viral and bacterial respiratory syndromes in the emergency department? A prospective cohort pilot study.

Venturini S, Crapis M, Zanus-Fortes A, Orso D, Cugini F, Fabro G Infection. 2025; .

PMID: 39821738 DOI: 10.1007/s15010-024-02468-7.


Optical Bionanosensors for Sepsis Diagnostics.

Derichsweiler C, Herbertz S, Kruss S Small. 2025; 21(8):e2409042.

PMID: 39745136 PMC: 11855245. DOI: 10.1002/smll.202409042.


Prognostic value of echocardiography parameters, peripheral blood T lymphocyte subpopulations, NF-κB, and CD64 levels in neonatal sepsis.

Yang X, Su Y, Liu G Am J Transl Res. 2024; 16(10):6140-6147.

PMID: 39544794 PMC: 11558375. DOI: 10.62347/BSGL8503.


CD64 Expression on Neutrophils (nCD64) as a Biomarker in Adult Patients With Sepsis: A Cross-Sectional Study.

Kanungo R, Hippargi S Cureus. 2024; 16(10):e71912.

PMID: 39429998 PMC: 11490971. DOI: 10.7759/cureus.71912.


References
1.
Matwiyoff G, Prahl J, Miller R, Carmichael J, Amundson D, Seda G . Immune regulation of procalcitonin: a biomarker and mediator of infection. Inflamm Res. 2012; 61(5):401-9. DOI: 10.1007/s00011-012-0439-5. View

2.
Huang W, Jiang W, Hu B, Ye H, Zeng H . [Significance of serum procalcitonin levels in the evaluation of severity and prognosis of patients with systemic inflammatory response syndrome]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2012; 24(5):294-7. View

3.
Tsalik E, Jaggers L, Glickman S, Langley R, van Velkinburgh J, Park L . Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med. 2011; 43(1):97-106. PMC: 3740117. DOI: 10.1016/j.jemermed.2011.05.072. View

4.
Tan T, Ahmad N, Nasuruddin D, Ithnin A, Tajul Arifin K, Zaini I . CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department. PLoS One. 2016; 11(3):e0152065. PMC: 4803226. DOI: 10.1371/journal.pone.0152065. View

5.
Feng L, Zhou X, Su L, Feng D, Jia Y, Xie L . Clinical significance of soluble hemoglobin scavenger receptor CD163 (sCD163) in sepsis, a prospective study. PLoS One. 2012; 7(7):e38400. PMC: 3401183. DOI: 10.1371/journal.pone.0038400. View